Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 20, 2022
Absci Corporation announced the opening of the Absci AI Research Lab in Manhattan’s Plaza District.
read more
Wednesday, April 20, 2022
Fast-growing contract development and manufacturing organization (CDMO) BORA Pharmaceuticals, has announced a planned investment of $10 million to expand its Oral Solid Dose capabilities across facilities in Zhunan, Taiwan and Mississauga, Ontario.
read more
Wednesday, April 20, 2022
Genovac announces that the company has acquired Carterra’s LSA platform for use in its discovery services.
read more
Catalent announced a multi-year $350 million investment at its facility in Bloomington, Indiana, to expand biologics drug substance and drug product manufacturing capabilities. The project will serve the industry’s robust biologics pipeline across ...
read more
Veeva Systems announced that Bristol Myers Squibb has implemented Veeva Vault CTMS globally to drive end-to-end trial management.
read more
BioConnection, an independent CDMO based in Oss, The Netherlands announced the completion of a new capital raising led by the European investment company Gimv, and supported by existing shareholders Pharming Group N.V., Mibiton and BioConnection’s ...
read more
Lonza and Integral Molecular announced a strategy to offer complementary expertise to their respective customers to better assess the risks of off-target binding of biologic drug candidates.
read more
Catalent has acquired from Erytech Pharma its state-of-the-art, commercial-scale cell therapy manufacturing facility in Princeton, New Jersey, for $44.5 million.
read more
Breckenridge Pharmaceutical, Inc. has signed a new-product agreement with PTS Pharma, LLC. under which PTS will support a technology transfer to Towa Pharmaceutical Europe, S.L. of a complex "For Suspension" product developed by PTS.
read more
ProteoNic and NecstGen announced a partnership for the development of improved viral vector manufacturing for gene therapy applications.
read more
ValGenesis Inc., and Zenovative have partnered to deliver compliance-focused digital validation solutions for pharmaceutical companies across the globe.
read more
Inotiv, Inc. announced the acquisition of Histion, LLC, effective April 25, 2022. The acquisition is a strategic element of the company’s expansion of its specialized pathology services.
read more
Sygnature Discovery has acquired Peak Proteins Ltd. Following an extensive partnership between the two companies, this deal will enable seamless integration of protein production and related structure determination projects within Sygnature. ...
read more
Wednesday, April 27, 2022
Societal CDMO, Inc. has been awarded a new manufacturing and packaging task order agreement by the National Cancer Institute’s Division of Cancer Treatment and Diagnosis (DCTD). The new contract is an individual task order of more than $400,000 for ...
read more
Wednesday, April 27, 2022
Biopharmaceutical contract development and manufacturing organization (CDMO) Scorpion Biological Services (Scorpion) today announced a planned development partnership with a private developer, the State of Kansas, and local and university affiliates,...
read more